CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
18 hedge funds and large institutions have $1.99M invested in CASI Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
18
Holding in Top 10
–
Calls
$17K
Puts
$9K
Top Buyers
| 1 | +$62.1K | |
| 2 | +$54.4K | |
| 3 | +$6.51K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.88K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$255 |
Top Sellers
| 1 | -$149K | |
| 2 | -$97.7K | |
| 3 | -$82.9K | |
| 4 |
Jane Street
New York
|
-$46.1K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$840 |